7707 Stock Overview
Precision System Science Co., Ltd., together with its subsidiaries, develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products in Japan and internationally.
Precision System Science Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||JP¥463.00|
|52 Week High||JP¥871.00|
|52 Week Low||JP¥360.00|
|1 Month Change||23.14%|
|3 Month Change||11.30%|
|1 Year Change||-43.19%|
|3 Year Change||8.43%|
|5 Year Change||-52.22%|
|Change since IPO||-80.56%|
Recent News & Updates
|7707||JP Life Sciences||JP Market|
Return vs Industry: 7707 underperformed the JP Life Sciences industry which returned -6.4% over the past year.
Return vs Market: 7707 underperformed the JP Market which returned -7.1% over the past year.
|7707 Average Weekly Movement||6.2%|
|Life Sciences Industry Average Movement||5.9%|
|Market Average Movement||4.2%|
|10% most volatile stocks in JP Market||8.5%|
|10% least volatile stocks in JP Market||2.3%|
Stable Share Price: 7707 is more volatile than 75% of JP stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 7707's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
Precision System Science Co., Ltd., together with its subsidiaries, develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products in Japan and internationally. The company manufactures and sells plastic consumables, which are used in automated systems/instruments, as well as reagents; and automated nucleic acid extraction and veterinary biochemical analysis systems. It also offers geneLEAD, an instrument for molecular testing; and engages in the research and development, and practical application of in vitro diagnosis testing market, including genetic and protein tests.
Precision System Science Fundamentals Summary
|7707 fundamental statistics|
Is 7707 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|7707 income statement (TTM)|
|Cost of Revenue||JP¥5.19b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Aug 12, 2022
|Earnings per share (EPS)||12.02|
|Net Profit Margin||4.20%|
How did 7707 perform over the long term?See historical performance and comparison
1.1%Current Dividend Yield
Is 7707 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 7707?
Other financial metrics that can be useful for relative valuation.
|What is 7707's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 7707's PE Ratio compare to its peers?
|7707 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
Price-To-Earnings vs Peers: 7707 is expensive based on its Price-To-Earnings Ratio (38.5x) compared to the peer average (15.5x).
Price to Earnings Ratio vs Industry
How does 7707's PE Ratio compare vs other companies in the Life Sciences Industry?
Price-To-Earnings vs Industry: 7707 is expensive based on its Price-To-Earnings Ratio (38.5x) compared to the JP Life Sciences industry average (17.5x)
Price to Earnings Ratio vs Fair Ratio
What is 7707's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||38.5x|
|Fair PE Ratio||22.7x|
Price-To-Earnings vs Fair Ratio: 7707 is expensive based on its Price-To-Earnings Ratio (38.5x) compared to the estimated Fair Price-To-Earnings Ratio (22.7x).
Share Price vs Fair Value
What is the Fair Price of 7707 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 7707 (¥463) is trading below our estimate of fair value (¥560.93)
Significantly Below Fair Value: 7707 is trading below fair value, but not by a significant amount.
Price to Earnings Growth Ratio
PEG Ratio: 7707 is poor value based on its PEG Ratio (1.2x)
Discover undervalued companies
How is Precision System Science forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score4/6
Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7707's forecast earnings growth (31.7% per year) is above the savings rate (0.02%).
Earnings vs Market: 7707's earnings (31.7% per year) are forecast to grow faster than the JP market (8.9% per year).
High Growth Earnings: 7707's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 7707's revenue (5.7% per year) is forecast to grow faster than the JP market (4.4% per year).
High Growth Revenue: 7707's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 7707's Return on Equity is forecast to be low in 3 years time (8.4%).
Discover growth companies
How has Precision System Science performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 7707 has high quality earnings.
Growing Profit Margin: 7707's current net profit margins (4.2%) are lower than last year (6.4%).
Past Earnings Growth Analysis
Earnings Trend: 7707 has become profitable over the past 5 years, growing earnings by 75.6% per year.
Accelerating Growth: 7707's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 7707 had negative earnings growth (-38.9%) over the past year, making it difficult to compare to the Life Sciences industry average (73.5%).
Return on Equity
High ROE: 7707's Return on Equity (5.2%) is considered low.
Discover strong past performing companies
How is Precision System Science's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 7707's short term assets (¥6.9B) exceed its short term liabilities (¥2.7B).
Long Term Liabilities: 7707's short term assets (¥6.9B) exceed its long term liabilities (¥1.9B).
Debt to Equity History and Analysis
Debt Level: 7707's net debt to equity ratio (3.2%) is considered satisfactory.
Reducing Debt: 7707's debt to equity ratio has reduced from 49.3% to 44.4% over the past 5 years.
Debt Coverage: 7707's debt is not well covered by operating cash flow (14.3%).
Interest Coverage: 7707's interest payments on its debt are well covered by EBIT (10.6x coverage).
Discover healthy companies
What is Precision System Science current dividend yield, its reliability and sustainability?
Dividend Score 1/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 7707's dividend (1.08%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.71%).
High Dividend: 7707's dividend (1.08%) is low compared to the top 25% of dividend payers in the JP market (3.76%).
Stability and Growth of Payments
Stable Dividend: 7707 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 7707 has only been paying a dividend for 9 years, and since then payments have fallen.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (41.6%), 7707's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 7707 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Hideji Tajima (73 yo)
Mr. Hideji Tajima has been the President and Chief Executive Officer of Precision System Science Co. Ltd. since June 1989. Mr. Tajima been the President of Precision System Science Europe GmbH since June 2...
Experienced Management: 7707's management team is seasoned and experienced (7.7 years average tenure).
Experienced Board: 7707's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Precision System Science Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Precision System Science Co., Ltd.
- Ticker: 7707
- Exchange: TSE
- Founded: 1985
- Industry: Life Sciences Tools and Services
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: JP¥10.583b
- Shares outstanding: 27.63m
- Website: https://www.pss.co.jp
Number of Employees
- Precision System Science Co., Ltd.
- 88 Kamihongou
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/24 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.